FDA Inspection 1051875 — Biomat USA Inc.
The FDA completed an inspection of Biomat USA Inc. on April 27, 2018 in Saint Paul, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 27, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Saint Paul, MN (United States)